164 related articles for article (PubMed ID: 33835011)
1. Water avoidance and modification of exit-site care with stoma bag results in reduced exit-site infection rate in peritoneal dialysis patients.
Soetendorp H; Kliuk-Ben Bassat O; Wasserman A; Schwartz D; Bedbalayev R; Faukman I; Grupper A
Clin Nephrol; 2021 Jun; 95(6):323-331. PubMed ID: 33835011
[TBL] [Abstract][Full Text] [Related]
2. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
5. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
[TBL] [Abstract][Full Text] [Related]
6. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
10. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
13. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
van Diepen AT; Tomlinson GA; Jassal SV
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
Sachar M; Shah A
Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
[TBL] [Abstract][Full Text] [Related]
15. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
16. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
[TBL] [Abstract][Full Text] [Related]
17. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
[TBL] [Abstract][Full Text] [Related]
18. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
[TBL] [Abstract][Full Text] [Related]
19. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.
Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG
Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421
[TBL] [Abstract][Full Text] [Related]
20. Exit site infections: systematic microbiologic and quality control are needed.
Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]